Experimentation with strategy and the evolution of dynamic capability in the Indian pharmaceutical sector

Athreye, S; Kale, D; Ramani, SV

Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/8152

Title:	Experimentation with strategy and the evolution of dynamic capability in the Indian pharmaceutical sector
Authors:	Athreye, S Kale, D Ramani, SV
Keywords:	International marketing;R&D management;Indian pharmaceutical sector;Corporate strategy
Issue Date:	2009
Publisher:	Oxford University Press
Citation:	Athreye, S, Kale, D and Ramani, SV. (2009). Experimentation with strategy and the evolution of dynamic capability in the Indian pharmaceutical sector. Industrial and Corporate Change, 18(4), 729-759.
Abstract:	This article demonstrates that radical regulatory changes can be tantamount to technological revolutions by studying Indian pharmaceutical firms. It shows that radical regulatory changes such as the Indian Patent Act of 1970, the New Industrial Policy of 1991 and the signing of TRIPS (Trade Related Intellectual Property Rights System) in 1995 served to open up new economic opportunities and constraints in the wake of which the winners and losers were selected as a function of the dynamic firm capabilities most appropriate for the new market environment.
Description:	The pre-refereed author version of this article was published as a UNI-MERIT Working Paper, which can be downloaded from the UNU-MERIT website from the following link: http://arno.unimaas.nl/show.cgi?fid=11179.
URI:	http://icc.oxfordjournals.org/content/18/4/729 http://bura.brunel.ac.uk/handle/2438/8152
DOI:	http://dx.doi.org/10.1093/icc/dtp024
ISSN:	1464-3650
Appears in Collections:	Business and Management Brunel Business School Research Papers

Files in This Item:

File	Description	Size	Format
Notice.pdf		40.05 kB	Adobe PDF	View/Open

Show full item record